These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9113130)

  • 21. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.
    Lindefors N; Brodin E; Tossman U; Segovia J; Ungerstedt U
    Exp Brain Res; 1989; 74(3):527-34. PubMed ID: 2468514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.
    Salvatore MF; Zhang JL; Large DM; Wilson PE; Gash CR; Thomas TC; Haycock JW; Bing G; Stanford JA; Gash DM; Gerhardt GA
    J Neurochem; 2004 Jul; 90(1):245-54. PubMed ID: 15198683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of neurotransmitter release by cholecystokinin in the neostriatum and substantia nigra of the rat: regional and receptor specificity.
    You ZB; Herrera-Marschitz M; Pettersson E; Nylander I; Goiny M; Shou HZ; Kehr J; Godukhin O; Hökfelt T; Terenius L; Ungerstedt U
    Neuroscience; 1996 Oct; 74(3):793-804. PubMed ID: 8884775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-cholinergic effects of acetylcholinesterase in the substantia nigra: a possible role for an ATP-sensitive potassium channel.
    Webb CP; Greenfield SA
    Exp Brain Res; 1992; 89(1):49-58. PubMed ID: 1350999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specificity of GABA as a stimulator of dopamine release in rat substantia nigra.
    Starr MS
    Neurosci Lett; 1980 May; 18(1):79-84. PubMed ID: 6133247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys.
    Gerhardt GA; Cass WA; Huettl P; Brock S; Zhang Z; Gash DM
    Brain Res; 1999 Jan; 817(1-2):163-71. PubMed ID: 9889359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo release of acetylcholinesterase in cat substantia nigra and caudate nucleus.
    Greenfield S; Cheramy A; Leviel V; Glowinski J
    Nature; 1980 Mar; 284(5754):355-7. PubMed ID: 7360271
    [No Abstract]   [Full Text] [Related]  

  • 28. GABA(A) receptors in the pars compacta and GABA(B) receptors in the pars reticulata of rat substantia nigra modulate the striatal dopamine release.
    Balon N; Kriem B; Weiss M; Rostain JC
    Neurochem Res; 2002 May; 27(5):373-9. PubMed ID: 12064352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GABA potentiates potassium-stimulated 3H-dopamine release from slices of rat substantia nigra and corpus striatum.
    Starr MS
    Eur J Pharmacol; 1978 Apr; 48(3):325-8. PubMed ID: 639860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetylcholinesterase has a non-cholinergic neuromodulatory action in the guinea-pig substantia nigra.
    Last AT; Greenfield SA
    Exp Brain Res; 1987; 67(2):445-8. PubMed ID: 3040458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum.
    Elverfors A; Nissbrandt H
    Neuropharmacology; 1992 Jul; 31(7):661-70. PubMed ID: 1328918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo characterization of somatodendritic dopamine release in the substantia nigra of 6-hydroxydopamine-lesioned rats.
    Sarre S; Yuan H; Jonkers N; Van Hemelrijck A; Ebinger G; Michotte Y
    J Neurochem; 2004 Jul; 90(1):29-39. PubMed ID: 15198664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic inhibition of the high-affinity dopamine uptake system increases oxidative damage to proteins in the aged rat substantia nigra.
    Romero-Ramos M; Rodríguez-Gómez JA; Venero JL; Cano J; Machado A
    Free Radic Biol Med; 1997; 23(1):1-7. PubMed ID: 9165291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.
    Izurieta-Sánchez P; Sarre S; Ebinger G; Michotte Y
    Eur J Pharmacol; 2000 Jul; 399(2-3):151-60. PubMed ID: 10884514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative involvement of globus pallidus and subthalamic nucleus in the regulation of somatodendritic dopamine release in substantia nigra is dopamine-dependent.
    Cobb WS; Abercrombie ED
    Neuroscience; 2003; 119(3):777-86. PubMed ID: 12809698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amphetamine-induced release of dopamine from the substantia nigra in vitro.
    Paden C; Wilson CJ; Groves PM
    Life Sci; 1976 Nov; 19(10):1499-506. PubMed ID: 994699
    [No Abstract]   [Full Text] [Related]  

  • 37. The relationship between visual stimulation, behaviour and continuous release of protein in the substantia nigra.
    Jones SA; Ellis JR; Klegeris A; Greenfield SA
    Brain Res; 1991 Sep; 560(1-2):163-6. PubMed ID: 1760724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo evidence for a dendritic release of dopamine in the cat substantia nigra.
    Chéramy A; Nieoullon A; Glowinski J
    Appl Neurophysiol; 1979; 42(1-2):57-9. PubMed ID: 453805
    [No Abstract]   [Full Text] [Related]  

  • 39. Endogenous opioids in dopaminergic cell body regions modulate amphetamine-induced increases in extracellular dopamine levels in the terminal regions.
    Schad CA; Justice JB; Holtzman SG
    J Pharmacol Exp Ther; 2002 Mar; 300(3):932-8. PubMed ID: 11861800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synaptosomal uptake and release of dopamine in substantia nigra: effects of gamma-aminobutyric acid and substance P.
    Silbergeld EK; Walters JR
    Neurosci Lett; 1979 Apr; 12(1):119-26. PubMed ID: 460694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.